Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 4, Pages 739
Publisher
MDPI AG
Online
2021-02-12
DOI
10.3390/cancers13040739
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death
- (2020) Hannah Maria Baumert et al. Cancer Cell International
- Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3
- (2020) Xuejiao Leng et al. ONCOGENE
- The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis
- (2019) Matthew G. Oser et al. GENES & DEVELOPMENT
- MLL2 promotes cancer cell lymph node metastasis by interacting with RelA and facilitating STC1 transcription
- (2019) Hongqi Li et al. CELLULAR SIGNALLING
- Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
- (2018) Elisabet Cuyàs et al. AGING CELL
- Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation
- (2018) Guiju Tang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma
- (2018) Abulajiang Abudureheman et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer
- (2018) Keqiang Zhang et al. Molecular Cancer
- Progress in the application and mechanism of metformin in treating non-small cell lung cancer
- (2017) Chan Li et al. Oncology Letters
- Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells
- (2017) Dong Hao Jin et al. Oncotarget
- Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer
- (2017) Sang-Won Um et al. Clinical Epigenetics
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner
- (2016) David Cano-Rodriguez et al. Nature Communications
- Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
- (2016) Ludovica Morera et al. Clinical Epigenetics
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Retinoblastoma Binding Protein 2 (RBP2) Promotes HIF-1α–VEGF-Induced Angiogenesis of Non-Small Cell Lung Cancer via the Akt Pathway
- (2014) Lei Qi et al. PLoS One
- Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
- (2014) X. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin inhibits histone H2B monoubiquitination and downstream gene transcription in human breast cancer cells
- (2014) YU DU et al. Oncology Letters
- Histone Demethylase RBP2 Promotes Lung Tumorigenesis and Cancer Metastasis
- (2013) Y.-C. Teng et al. CANCER RESEARCH
- H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation
- (2013) Shannon M. Lauberth et al. CELL
- Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
- (2013) Jason D Buenrostro et al. NATURE METHODS
- The future of epigenetic therapy in solid tumours—lessons from the past
- (2013) Nilofer Azad et al. Nature Reviews Clinical Oncology
- RBP2 Induces Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer
- (2013) Shikun Wang et al. PLoS One
- MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets
- (2012) Zhen Shao et al. GENOME BIOLOGY
- Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
- (2011) Felix Krueger et al. BIOINFORMATICS
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon
- (2010) Thanemozhi G Natarajan et al. Cancer Cell International
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
- (2010) Adem Kalender et al. Cell Metabolism
- The Histone Demethylase RBP2 Is Overexpressed in Gastric Cancer and Its Inhibition Triggers Senescence of Cancer Cells
- (2009) Jiping Zeng et al. GASTROENTEROLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- KEGG for representation and analysis of molecular networks involving diseases and drugs
- (2009) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation
- (2008) Ali Shilatifard CURRENT OPINION IN CELL BIOLOGY
- Molecular Regulation of H3K4 Trimethylation by Wdr82, a Component of Human Set1/COMPASS
- (2008) M. Wu et al. MOLECULAR AND CELLULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now